Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo
2012-01-01 Sulaiman, Gm; Ad'Hiah, Ah; Al-Sammarrae, Kw; Bagnati, R; Frapolli, R; Bello, E; Uboldi, S; Romano, M; Panini, N; Scanziani, E; Pezzolato, M; Erba, E; D'Incalci, M
G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors
2008-01-01 Leonetti, C; Scarsella, M; Riggio, G; Rizzo, A; Salvati, E; D'Incalci, M; Staszewsky, L; Frapolli, R; Stevens, Mf; Stoppacciaro, A; Mottolese, M; Antoniani, B; Gilson, E; Zupi, G; Biroccio, A
Pharmacokinetic assessment of novel oral taxane derivatives in mice
2005-01-01 Marangon, E; Falcioni, C; Manzotti, C; Fontana, G; Morazzoni, P; D'Incalci, M; Zucchetti, M
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
2007-01-01 Cavaletti, G; Gilardini, A; Canta, A; Rigamonti, L; Rodriguez-Menendez, V; Ceresa, C; Marmiroli, P; Bossi, M; Oggioni, N; D'Incalci, M; De Coster, R
Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma
2006-01-01 Grosso, F; Dileo, P; Sanfilippo, R; Stacchiotti, S; Bertulli, R; Piovesan, C; Jimeno, J; D'Incalci, M; Gescher, A; Casali, Pg
Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound
1999-01-01 Bergamaschi, D; Ronzoni, S; Taverna, S; Faretta, M; De Feudis, P; Faircloth, G; Jimeno, J; Erba, E; D'Incalci, M
L-asparagine-depletion: Another opinion - Response
1997-01-01 Rizzari, C; Conter, V; D'Incalci, M; Masera, G
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
2010-01-01 Salvati, E; Scarsella, M; Porru, M; Rizzo, A; Iachettini, S; Tentori, L; Graziani, G; D'Incalci, M; Stevens, Mfg; Orlandi, A; Passeri, D; Gilson, E; Zupi, G; Leonetti, C; Biroccio, A
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
2017-01-01 Campaner, E; Rustighi, A; Zannini, A; Cristiani, A; Piazza, S; Ciani, Y; Kalid, O; Golan, G; Baloglu, E; Shacham, S; Valsasina, B; Cucchi, U; Pippione, Ac; Lolli, Ml; Giabbai, B; Storici, P; Carloni, P; Rossetti, G; Benvenuti, F; Bello, E; D'Incalci, M; Cappuzzello, E; Rosato, A; Del Sal, G
Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth
2014-01-01 Grohar, Pj; Segars, Le; Yeung, C; Pommier, Y; D'Incalci, M; Mendoza, A; Helman, Lj
Special issue - Gene transcription and cancer, from the genome project to practical achievements in diagnosis and therapy
2004-01-01 D'Incalci, M; Dulbecco, R
Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer
1997-01-01 Codegoni, Am; Broggini, M; Pitelli, Mr; Pantarotto, M; Torri, V; Mangioni, C; D'Incalci, M
Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours
1999-01-01 Gander, M; Leyvraz, S; Decosterd, L; Bonfanti, M; Marzolini, C; Shen, F; Lienard, D; Perey, L; Colella, G; Biollaz, J; Lejeune, F; Yarosh, D; Belanich, M; D'Incalci, M
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences
2010-01-01 Azzariti, A; Porcelli, L; Simone, Gm; Quatrale, Ae; Colabufo, Na; Berardi, F; Perrone, R; Zucchetti, M; D'Incalci, M; Xu, Jm; Paradiso, A
Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243)
1999-01-01 Sessa, C; Zucchetti, M; Ghielmini, M; Bauer, J; D'Incalci, M; de Jong, J; Naegele, H; Rossi, S; Pacciarini, Ma; Domenigoni, L; Cavalli, F
Glutathione S-transferase activity in epithelial ovarian cancer: Association with response to chemotherapy and disease outcome
1997-01-01 Ferrandina, G; Scambia, G; Damia, G; Tagliabue, G; Fagotti, A; Panici, Pb; Mangioni, C; Mancuso, S; D'Incalci, M
Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kinetics
2013-01-01 Ferrari, R; Colombo, C; Casali, C; Lupi, M; Ubezio, P; Falcetta, F; D'Incalci, M; Morbidelli, M; Moscatelli, D
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model
2006-01-01 Cavaletti, G; Gilardini, A; Canta, A; Rigamonti, L; Menendez, Vr; Oggioni, N; Marmiroli, P; D'Incalci, M; De Coster, R
Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways
2001-01-01 Damia, G; Silvestri, S; Carrassa, L; Filiberti, L; Faircloth, Gt; Liberi, G; Foiani, M; D'Incalci, M
A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
2012-01-01 Scarpati, Gd; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; De Stefano, A; Singh, Vk; D'Incalci, M; De Placido, S; Pepe, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo | 1-gen-2012 | Sulaiman, Gm; Ad'Hiah, Ah; Al-Sammarrae, Kw; Bagnati, R; Frapolli, R; Bello, E; Uboldi, S; Romano, M; Panini, N; Scanziani, E; Pezzolato, M; Erba, E; D'Incalci, M | |
| G-Quadruplex Ligand RHPS4 Potentiates the Antitumor Activity of Camptothecins in Preclinical Models of Solid Tumors | 1-gen-2008 | Leonetti, C; Scarsella, M; Riggio, G; Rizzo, A; Salvati, E; D'Incalci, M; Staszewsky, L; Frapolli, R; Stevens, Mf; Stoppacciaro, A; Mottolese, M; Antoniani, B; Gilson, E; Zupi, G; Biroccio, A | |
| Pharmacokinetic assessment of novel oral taxane derivatives in mice | 1-gen-2005 | Marangon, E; Falcioni, C; Manzotti, C; Fontana, G; Morazzoni, P; D'Incalci, M; Zucchetti, M | |
| Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat | 1-gen-2007 | Cavaletti, G; Gilardini, A; Canta, A; Rigamonti, L; Rodriguez-Menendez, V; Ceresa, C; Marmiroli, P; Bossi, M; Oggioni, N; D'Incalci, M; De Coster, R | |
| Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma | 1-gen-2006 | Grosso, F; Dileo, P; Sanfilippo, R; Stacchiotti, S; Bertulli, R; Piovesan, C; Jimeno, J; D'Incalci, M; Gescher, A; Casali, Pg | |
| Cell cycle perturbations and apoptosis induced by isohomohalichondrin B (IHB), a natural marine compound | 1-gen-1999 | Bergamaschi, D; Ronzoni, S; Taverna, S; Faretta, M; De Feudis, P; Faircloth, G; Jimeno, J; Erba, E; D'Incalci, M | |
| L-asparagine-depletion: Another opinion - Response | 1-gen-1997 | Rizzari, C; Conter, V; D'Incalci, M; Masera, G | |
| PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy | 1-gen-2010 | Salvati, E; Scarsella, M; Porru, M; Rizzo, A; Iachettini, S; Tentori, L; Graziani, G; D'Incalci, M; Stevens, Mfg; Orlandi, A; Passeri, D; Gilson, E; Zupi, G; Leonetti, C; Biroccio, A | |
| A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action | 1-gen-2017 | Campaner, E; Rustighi, A; Zannini, A; Cristiani, A; Piazza, S; Ciani, Y; Kalid, O; Golan, G; Baloglu, E; Shacham, S; Valsasina, B; Cucchi, U; Pippione, Ac; Lolli, Ml; Giabbai, B; Storici, P; Carloni, P; Rossetti, G; Benvenuti, F; Bello, E; D'Incalci, M; Cappuzzello, E; Rosato, A; Del Sal, G | |
| Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth | 1-gen-2014 | Grohar, Pj; Segars, Le; Yeung, C; Pommier, Y; D'Incalci, M; Mendoza, A; Helman, Lj | |
| Special issue - Gene transcription and cancer, from the genome project to practical achievements in diagnosis and therapy | 1-gen-2004 | D'Incalci, M; Dulbecco, R | |
| Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer | 1-gen-1997 | Codegoni, Am; Broggini, M; Pitelli, Mr; Pantarotto, M; Torri, V; Mangioni, C; D'Incalci, M | |
| Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours | 1-gen-1999 | Gander, M; Leyvraz, S; Decosterd, L; Bonfanti, M; Marzolini, C; Shen, F; Lienard, D; Perey, L; Colella, G; Biollaz, J; Lejeune, F; Yarosh, D; Belanich, M; D'Incalci, M | |
| Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences | 1-gen-2010 | Azzariti, A; Porcelli, L; Simone, Gm; Quatrale, Ae; Colabufo, Na; Berardi, F; Perrone, R; Zucchetti, M; D'Incalci, M; Xu, Jm; Paradiso, A | |
| Phase I clinical and pharmacological study of oral methoxymorpholinyl doxorubicin (PNU 152243) | 1-gen-1999 | Sessa, C; Zucchetti, M; Ghielmini, M; Bauer, J; D'Incalci, M; de Jong, J; Naegele, H; Rossi, S; Pacciarini, Ma; Domenigoni, L; Cavalli, F | |
| Glutathione S-transferase activity in epithelial ovarian cancer: Association with response to chemotherapy and disease outcome | 1-gen-1997 | Ferrandina, G; Scambia, G; Damia, G; Tagliabue, G; Fagotti, A; Panici, Pb; Mangioni, C; Mancuso, S; D'Incalci, M | |
| Synthesis of surfactant free PCL-PEG brushed nanoparticles with tunable degradation kinetics | 1-gen-2013 | Ferrari, R; Colombo, C; Casali, C; Lupi, M; Ubezio, P; Falcetta, F; D'Incalci, M; Morbidelli, M; Moscatelli, D | |
| Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model | 1-gen-2006 | Cavaletti, G; Gilardini, A; Canta, A; Rigamonti, L; Menendez, Vr; Oggioni, N; Marmiroli, P; D'Incalci, M; De Coster, R | |
| Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways | 1-gen-2001 | Damia, G; Silvestri, S; Carrassa, L; Filiberti, L; Faircloth, Gt; Liberi, G; Foiani, M; D'Incalci, M | |
| A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | 1-gen-2012 | Scarpati, Gd; Falcetta, F; Carlomagno, C; Ubezio, P; Marchini, S; De Stefano, A; Singh, Vk; D'Incalci, M; De Placido, S; Pepe, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891